NextGen Healthcare (NASDAQ:NXGN) Price Target Lowered to $22.00 at Guggenheim

NextGen Healthcare (NASDAQ:NXGN – Get Rating) had its price objective decreased by Guggenheim from $26.00 to $22.00 in a research note issued to investors on Tuesday morning, The Fly reports.

NXGN has been the subject of several other research reports. Stephens initiated coverage on shares of NextGen Healthcare in a report on Tuesday, April 11th. They set an overweight rating and a $24.00 price target for the company. Piper Sandler lowered their price target on NextGen Healthcare from $20.00 to $17.00 in a research note on Thursday, May 18th. Truist Financial cut their price target on NextGen Healthcare from $22.00 to $18.00 in a report on Monday. TheStreet lowered NextGen Healthcare from a b- rating to a c rating in a research note on Tuesday, May 16th. Finally, StockNews.com assumed coverage on NextGen Healthcare in a report on Thursday, May 18th. They issued a buy rating for the company. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, NextGen Healthcare currently has an average rating of Moderate Buy and a consensus target price of $21.20.

NextGen Healthcare Trading Up 0.1 %

NXGN opened at $15.66 on Tuesday. The company has a quick ratio of 2.53, a current ratio of 2.03 and a debt-to-equity ratio of 0.67. The firm’s 50 day moving average is $17.04 and its 200-day moving average is $18.18. The firm has a market capitalization of $1.03 billion, a P/E ratio of -391.50 and a beta of 1.04. NextGen Healthcare has a 52-week low of $15.23 and a 52-week high of $21.99.

Hedge Funds Weigh In On NextGen Healthcare

Institutional investors have recently modified their holdings of the business. Point72 Hong Kong Ltd bought a new position in shares of NextGen Healthcare during the 3rd quarter valued at about $40,000. Tower Research Capital LLC TRC lifted its stake in NextGen Healthcare by 146.4% in the 1st quarter. Tower Research Capital LLC TRC now owns 2,363 shares of the company’s stock valued at $41,000 after acquiring an additional 1,404 shares in the last quarter. Altshuler Shaham Ltd lifted its stake in NextGen Healthcare by 98.7% in the 4th quarter. Altshuler Shaham Ltd now owns 3,205 shares of the company’s stock valued at $60,000 after acquiring an additional 1,592 shares in the last quarter. Captrust Financial Advisors lifted its stake in NextGen Healthcare by 61.5% in the 1st quarter. Captrust Financial Advisors now owns 4,255 shares of the company’s stock valued at $89,000 after acquiring an additional 1,620 shares in the last quarter. Finally, Point72 Middle East FZE bought a new stake in NextGen Healthcare in the 4th quarter valued at approximately $97,000. Institutional investors own 73.70% of the company’s stock.

NextGen Healthcare Company Profile

(Get Rating)

NextGen Healthcare, Inc provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange.